VBI-1901: SNO Phase 2a Data & Clinical Update
VBI-1901: SNO Phase 2a Data & Clinical UpdateПодробнее
VBI-1901 Therapeutic Cancer Vaccine DesignПодробнее
SeDiv New Version 2024 - Test MiniZone Seagate A5Подробнее
VBI Preclinical Coronavirus Program Data WebcastПодробнее
VBI-1901: AACR Data and Clinical UpdateПодробнее
BSI 2.0 on Vivid Ultra EditionПодробнее
FILTRATION PROCESSПодробнее
VBI: eVLP PlatformПодробнее
BO-112: Enhancing immune-checkpoint inhibition in solid tumorsПодробнее
Preclinical Studies in Glioblastoma Multiforme ("GBM")Подробнее
VBI Video Case StudyПодробнее
Blackwall Tunnel - Scan to BIMПодробнее
VBI Vaccines: Preclinical Covid Study related results announcement by CEO Jeff Baxter.Подробнее
Monoblue - Optimizing each step of membrane staining (Efficiency)Подробнее
VBI vaccines to be tested at the Ottawa HospitalПодробнее
Bispecifics & CARs: BCMA, GPRC5D & FcRH5 sequencingПодробнее
Biomarkers to help predict response to CDK4/6 inhibitorsПодробнее
VBI Vaccines: VBI-1901 (rGBM) discussion during Oppenheimer 31st Annual Healthcare ConferenceПодробнее
Is the 501Y.V2 variant more severe?Подробнее
